SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Singapore

SyntheticMR announced today that their quantitative imaging software solution SyMRI 12.1 has received regulatory approval in Singapore and can be sold and distributed in this market. 

“We are thrilled to receive regulatory approval in Singapore, we look forward to starting providing this market with our unique software SyMRI,” says Ulrik Harrysson, CEO at SyntheticMR. “We keep working on our goal to establish SyMRI as a standard of care globally and to support customers and clinicians from all over the world in their daily workflows. This regulatory approval in Singapore is a vital step on that journey.” 

SyMRI provides multiple contrast-weighted images and quantitative information about the patient in a single fast scan, enabling users to speed up their imaging workflow and add objective decision support to their practice. 

Learn more about SyMRI and what this exciting expansion has to offer!